2 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow XW001: new trials by email Literature Review of XW001 trials Research Report on XW001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV XW001, Placebo - RSV Infection | Phase 1 / Phase 2 | Completed | Hangzhou Sciwind Biosciences Co., Ltd. | 61 | 2023-04-20 | 2025-08-17 |
| Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy XW001, Placebo - COVID-19 Acute Respiratory Distress Syndrome | Phase 2 | Withdrawn | Sciwind Biosciences APAC CO Pty. Ltd. | 2021-10-30 | 2023-08-21 | |
| A Study of XW001 in Healthy Adult Subjects XW001, Placebo - Respiratory Syncytial Virus Infections | Phase 1 | Completed | Hangzhou Sciwind Biosciences Co., Ltd. | 81 | 2021-01-03 | 2023-03-08 |
Respiratory Syncytial Virus Infections (2) · Respiratory Distress Syndrome (1)
Hangzhou Sciwind Biosciences Co., Ltd. (2) · Sciwind Biosciences APAC CO Pty. Ltd. (1)
China (2) · Argentina (1) · Peru (1)
Eddie Angles (1) · Hanmin Liu, Dr (1) · Qin Yu (1) · Ricardo Teijeiro (1) · Xin Li (1)